DFB Pharmaceuticals
Practical innovations for life

NanOlogy

Better together.

 
 

Nanology, LLC is our partnership with CritiTech Drug Development Services, LLC and US Biotest, Inc. that is focused on the development of proven drugs for local delivery of sterile nanoparticle suspensions by infusion, instillation, direct injection, or inhalation in a variety of clinical applications related to oncology.

  • CritiTech are experts in the development and production of nanoparticulate forms of a variety of drug classes, including challenging substances and poorly soluble compounds, using the company’s proprietary Supercritical Precipitation Technology (SCP Technology). This produces a unique particle with a decrease in size, increase in accessible surface area, and increase in dissolution rate leading to improved bioavailability. Visit CritiTech.com >
  • US Biotest is dedicated to the development of novel therapeutics to address unmet medical needs. Led by Dr. Gere DiZerega, Chief Medical Office for Nanology, the company has strong relationships with industry experts, academic institutions, and leading physicians, and provides clinical expertise, development strategy, clinical research, and project management support for the efficient and rapid execution of preclinical and clinical trials.

Primary delivery forms

  • Sterile saline suspension of NanoPac® Nanoparticle Paclitaxel for intraperitoneal instillation, and direct injection into tissue, tumors, and cysts

  • NanoPac® Nanoparticle Paclitaxel powder for nebulized lung inhalation

  • Sterile saline suspension of NanoDoce® Nanoparticle Docetaxel for intravesicle instillation, and direct injection into tumors

DFB Soria® LLC

Affiliated with Nanology, DFB Soria is our partnership with US Biotest, with an exclusive license from CritiTech, that is focused on the development of nanoparticle forms of existing drugs for topical delivery in a variety of applications in dermatology, women’s health, and oncology.

Primary delivery forms

  • SOR007: A suspension NanoPac® Nanoparticle Paclitaxel in a penetrating anhydrous siloxane emollient base for topical delivery